Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-dose hCG plus GnRH agonist to reduce ovarian hyperstimulation syndrome in IVF cycles
IRCT2016031427045N1Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Dec 2015
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, single-arm trial of human chorionic gonadotropin and gonadotropin-releasing hormone agonist in female infertility, sponsored by Tehran University of Medical Sciences. Started Dec 2015; status: completed.
02
Drugs
human chorionic gonadotropingonadotropin-releasing hormone agonist
03
Conditions
female infertility
Beyond the preview
Go deeper on IRCT2016031427045N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2016031427045N1.